Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia

PHASE3CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

October 29, 2009

Primary Completion Date

September 17, 2012

Study Completion Date

December 1, 2014

Conditions
Familial Hypercholesterolemia
Interventions
DRUG

lomitapide

5-60 mg po every day

Trial Locations (10)

7925

University of Capetown, Cape Town

9300

Cardiology Research, Bloemfontein

19104

University of Pennsylvania, Philadelphia

90048

Cedars-Sinai Medical Center, Los Angeles

N6A 5K8

Robarts Research Institute, London

G7H 5H6

Lipid Clinic and University of Montreal Community Genomic Medicine Center, Chicoutimi

Unknown

Medicina Interna Universitaria, Ferrara

Dipartimento di Medicina Clinica e Delle Patologie Emergenti, Palermo

Centro Universitario Dislipidemie, Milan

DAI Ematologia, Oncologia, Anatomia Patologica e Medicina, Roma

Sponsors
All Listed Sponsors
lead

Aegerion Pharmaceuticals, Inc.

INDUSTRY

NCT00943306 - Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia | Biotech Hunter | Biotech Hunter